Cloned Gene From Sea Animal May Prove Key In Cancer Drug Development 
10/19/2005 5:12:31 PM

Researchers at Scripps Institution of Oceanography at the University of California, San Diego, and their colleagues have taken a significant step forward in developing a new method to produce drug compounds with potential to treat various types of cancer. In the current issue of the journal Chemistry and Biology, scientists at Scripps, the University of Minnesota and the Life Sciences Institute describe the development of "bryA," a gene that could help solve problems associated with the production of anticancer agents originally discovered in the marine invertebrate Bugula neritina.